| Name | Title | Contact Details |
|---|
Proximie is a technology platform that uses a combination of machine learning, artificial intelligence and augmented reality to allow clinicians to virtually scrub in and collaborate with each other from anywhere in the world.
St. Jude Medical is a global medical device manufacturer dedicated to transforming the treatment of some of the world’s most expensive epidemic diseases. We do this by developing cost-effective medical technologies that save and improve lives. St. Jude Medical provides safe and effective technologies that are of the highest quality—and that quality is something we take very seriously because we know patients around the world rely on our technologies. Our approximately 18,000 employees are passionate in their commitment to this priority. Headquartered in St. Paul, Minn., St. Jude Medical has four major clinical focus areas: cardiac rhythm management, atrial fibrillation, cardiovascular and neuromodulation. The St. Jude Medical product portfolio includes implantable cardioverter defibrillators (ICDs), cardiac resynchronization therapy (CRT) devices, pacemakers, remote monitoring systems, cardiac mapping and visualization systems, catheter-based ablation devices, vascular closure devices, structural heart products, spinal cord stimulation, peripheral nerve stimulation and deep brain stimulation devices. All qualified applicants will receive consideration for employment without regard to race, color, creed, religion, sex, national origin, marital status, age, citizenship, protected veteran status, sexual orientation, gender identity and/or gender expression, status with respect to public assistance, or disability status.
CancerConsultants.com is a Ketchum, ID-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
KSQ Therapeutics has built an industry-leading genome-scale precision functional genomics platform, called CRISPRomics, to pinpoint therapeutic nodes that directly correlate genomic function to disease with unprecedented certainty and speed. The company is deploying CRISPRomics for novel drug development across broad therapeutic areas and is currently advancing a proprietary pipeline of tumor- and immune-focused drug candidates. KSQ was founded by thought leaders in the field of functional genomics and pioneers of CRISPR screening technologies, and the company is located in Cambridge, Massachusetts.